Product Information
VALTOCO 5 MG NASAL SPRAY is a brand product labeled by Neurelis, Inc, priced at $366.8626 per EA under NDC 72252050502. Its NADAC has been published 209 times since May 18, 2022.
FDA first approved this application on Jan 10, 2020.
Strength
5 mg/.1mL
Manufacturer
Neurelis, IncNDC
72252050502
Classification
Brand
Dosage Form
SPRAY
Route
NASAL
Effective Date
1/1/2026
Active Ingredients
DIAZEPAMApproval Type
New Drug (NDA)
FDA Application
NDA211635FDA Approved
1/10/2020
On Market Since
1/10/2020
Pharmacological Classes
Price Statistics
The NADAC for VALTOCO 5 MG NASAL SPRAY has been published 209 times since May 18, 2022, and over the history we have for it it has risen 22.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $366.8626 per EA |
|---|---|
| All-time high | $366.8626 (May 13, 2026) |
| All-time low | $299.0490 (May 18, 2022) |
| 52-week high | $366.8626 |
| 52-week low | $351.0681 |
| Median price | $333.1901 |
| Average price | $331.4033 |
| Largest weekly change | +6.0% (Jan 4, 2023) |
| Weeks tracked | 209 |
| Tracking since | May 18, 2022 |
1W
N/A
1M
N/A
3M
N/A
6M
0.0%
1Y
+4.5%
3Y
+15.7%
5Y
N/A
All
+22.7%
Last surveyed May 13, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Neurelis, Inc manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
diazepam market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Benzodiazepine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VALTOCO 5 MG NASAL SPRAY?
The current National Average Drug Acquisition Cost (NADAC) for VALTOCO 5 MG NASAL SPRAY, manufactured by Neurelis, Inc, is $366.8626 per EA (NDC 72252050502), effective May 13, 2026.
How has the price of VALTOCO 5 MG NASAL SPRAY changed over time?
Over the history we have for it, the NADAC for VALTOCO 5 MG NASAL SPRAY has risen 22.7%. It has been tracked across 209 weekly CMS publications since May 18, 2022.
What are the highest and lowest recorded NADAC prices for VALTOCO 5 MG NASAL SPRAY?
Since May 18, 2022, the NADAC for VALTOCO 5 MG NASAL SPRAY has ranged from a low of $299.0490 (May 18, 2022) to a high of $366.8626 (May 13, 2026), with a median of $333.1901 per EA.
Are there cheaper alternatives to VALTOCO 5 MG NASAL SPRAY?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, VALTOCO 5 MG NASAL SPRAY, is $366.1435 per EA — about 0% below VALTOCO 5 MG NASAL SPRAY.
Who manufactures VALTOCO 5 MG NASAL SPRAY?
VALTOCO 5 MG NASAL SPRAY (NDC 72252050502) is labeled by Neurelis, Inc, and CMS classifies it as a brand product.